Jeremy S. Abramson, Matthew Ku, Mark Hertzberg, Christopher P. Fox, Charles Herbaux, Dok Hyun Yoon, Won Seog Kim, Huilai Zhang, Haifaa Abdulhaq, William Townsend, Estefania Mulvihill, Victor Orellana-Noia, Richard Ta, Huang Huang, Martine Kallemeijn, Anton Belousov, Alessia Bottos, Linda Lundberg, Gareth P. Gregory. "Glofitamab plus gemcitabine and oxaliplatin (Glofit-GemOx) in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): 2-year (yr) follow-up of STARGLO.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7015